CAR T cells produce longest survival in low disease burden ALL patientsJanuary 31, 2018Leukemia, Myelodysplasia, TransplantationImmunotherapy
Tisagenlecleucel looks effective in phase 2 study of young ALL patientsJanuary 31, 2018Leukemia, Myelodysplasia, TransplantationPediatrics
Contaminated graft causes infection in ALL patientJanuary 30, 2018Leukemia, Myelodysplasia, Transplantation
mIDH inhibitors could fill treatment gap in AMLJanuary 25, 2018Leukemia, Myelodysplasia, Transplantation
Sotatercept promising for treatment of anemia in MDSJanuary 24, 2018Leukemia, Myelodysplasia, Transplantation
Immunotherapy with less intense chemotherapy safe and effective for older patients with ALLJanuary 21, 2018Patient & Survivor CareLeukemia, Myelodysplasia, Transplantation
RELAZA2: MRD-guided azacitidine reduces relapse risk in MDS and AMLJanuary 21, 2018Leukemia, Myelodysplasia, Transplantation
FDA approves injection treatment for low-risk APLJanuary 17, 2018Leukemia, Myelodysplasia, Transplantation
Children with pathogenic TP53 variants face increased risk of hard-to-treat ALLJanuary 16, 2018Leukemia, Myelodysplasia, Transplantation
DNA sequencing could help identify relapse risk in treated AMLJanuary 4, 2018Leukemia, Myelodysplasia, Transplantation
Sorafenib plus chemo prolongs event-free survival in AMLJanuary 3, 2018Leukemia, Myelodysplasia, Transplantation
FDA expands indication for bosutinib in newly diagnosed CMLJanuary 2, 2018Leukemia, Myelodysplasia, Transplantation
Venetoclax/rituximab boosts PFS in relapsed/refractory CLLDecember 27, 2017Leukemia, Myelodysplasia, Transplantation
FDA updates nilotinib product label outlining criteria for discontinuationDecember 27, 2017Leukemia, Myelodysplasia, Transplantation
VIDEO: Joint FDA-ASH session highlights new AML drugsDecember 14, 2017Leukemia, Myelodysplasia, Transplantation
